CLINICAL_TRIALS
trial_result
· 2018-05-16
Clinical Trial Update: Eplerenone for Central Serous Chorioretinopathy [Phase 2]
Summary
Tufts Medical Center completed a Phase 2 trial of eplerenone for Central Serous Chorioretinopathy and posted results in May 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tufts Medical Center | Conditions: Central Serous Chorioretinopathy | Phase 2 | Status: COMPLETED | Results posted: 2018-05-16